Magnesium and affective disorders

Nutritional Neuroscience

Volumn 5, Issue 6, 2002, Pages 375-389

  Murck, H ^a  

^a Laxdale Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMPHETAMINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; APOMORPHINE; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CARRIER PROTEIN; CORTICOSTEROID; CORTICOTROPIN; GLYCOPROTEIN P; LITHIUM; MAGNESIUM; MAGNESIUM ION; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PLACEBO; PROTEIN KINASE C; PYRIDOXINE; PYROGLUTAMIC ACID; TRYPTOPHAN; UNINDEXED DRUG; VERAPAMIL; VIGABATRIN;

BLOOD BRAIN BARRIER; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CLINICAL STUDY; CORTICOTROPIN RELEASE; DEPRESSION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; ELECTROENCEPHALOGRAM; ENDOCRINE SYSTEM; HIPPOCAMPUS; HORMONE SENSITIVITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KINDLING; LIMBIC CORTEX; MOOD DISORDER; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SLEEP;

ADRENAL GLANDS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; KINDLING, NEUROLOGIC; LITHIUM; LOCUS COERULEUS; MAGNESIUM; MOOD DISORDERS; PITUITARY GLAND; SLEEP;

EID: 0036904630     PISSN: 1028415X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1028415021000039194     Document Type: Review

References (213)

1. Abe, K. and Saito, H. (2000) "Involvement of Na + - K + pump in L-glutamate clearance by cultured rat cortical astrocytes", Biological and Pharmaceutical Bulletin 23, 1051-1054.
2. Aeschbach, D., Dijk, D.J., Trachsel, L., Brunner, D.P. and Borbely, A.A. (1994) "Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone", Neuropsychopharmacology 11, 237-244.
3. Aguilera, G., Young, W.S., Kiss, A. and Bathia, A. (1995) "Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II", Neuroendocrinology 61, 437-444.
4. Altura, B.M., Altura, B.T., Gebrewold, A., Ising, H. and Gunther, T. (1992) "Noise-induced hypertension and magnesium in rats: relationship to microcirculation and calcium", Journal of Applied Physiology 72, 194-202.
5. Amyard, N., Leyris, A., Monier, C., Frances, H., Boulu, R.G. and Henrotte, J.G. (1995) "Brain catecholamines, serotonin and their metabolites in mice selected for low (MGL) and high (MGH) blood magnesium levels", Magnesium Research 8, 5-9.
6. Antonijevic, I.A., Murck, H., Frieboes, R.M. and Steiger, A. (2000) "Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls-part II: hormone secretion", Sleep Research Online 3, 15-21.
7. Atarashi, K., Takagi, M., Matsuoka, H. and Sugimoto, T. (1990) "Effects of magnesium on changes in blood pressure and plasma aldosterone induced by angiotensin II", American Journal of Hypertension 3, 488-490.
8. Austin, L.S., Arana, G.W. and Melvin, J.A. (1990) "Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients", Journal of Clinical Psychiatry 51, 344-345.
9. Avissar, S., Murphy, D.L. and Schreiber, G. (1991) "Magnesium reversal of lithium inhibition of beta-adrenergic and muscarinic receptor coupling to G proteins", Biochemistry and Pharmacology 41, 171-175.
10. Bac, P., Maurois, P., Dupont, C., Pages, N., Stables, J.P., Gressens, P., Evrard, P. and Vamecq, J. (1998) "Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection properties", Journal of Neuroscience 18, 4363-4373.
11. Bader, M. and Ganten, D. (2000) "Regulation of renin: new evidence from cultured cells and genetically modified mice", Journal of Molecular Medicine 78, 130-139.
12. Bailey, T.W. and Dimicco, J.A. (2001) "Chemical stimulation of the dorsomedial hypothalamus elevates plasma ACTH in conscious rats", American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 280, R8-R15.
13. Banki, C.M., Vojnik, M., Papp, Z., Balla, K.Z. and Arato, M. (1985) "Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts", Biological Psychiatry 20, 163-171.
14. Barnes, R.F., Veith, R.C., Borson, S., Verhey, J., Raskind, M.A. and Halter, J.B. (1983) "High levels of plasma catecholamines in dexamethasone-resistant depressed patients", American Journal of Psychiatry 140, 1623-1625.
15. Bartholini, G. (1984) "Experimental basis for the antidepressant action of the GABA receptor agonist progabide", Neuroscience Letters 47, 351-355.
16. Belmaker, R.H. (1984) "Adenylate cyclase and the search for new compounds with the clinical profile of lithium", Pharmacopsychiatry 17, 9-15.
17. Berecek, K.H., Coshatt, G., Narkates, A.J., Oparil, S., Wilson, K.M. and Robertson, J. (1988) "Captopril and the response to stress in the spontaneously hypertensive rat", Hypertension 11, 1144-1147.
18. Billiard, M. (1987) "Lithium carbonate: effects on sleep patterns of normal and depressed subjects and its use in sleep-wake pathology", Pharmacopsychiatry 20, 195-196.
19. Birch, N.J. (1975) "Letter: lithium and magnesium-dependent processes", Lancet 1, 1384.
20. Bjorum, N. (1972) "Electrolytes in blood in endogenous depression", Acta Psychiatrica Scandinavica 48, 59-68.
21. Brandon, N.J., Delmas, P., Kittler, J.T., McDonald, B.J., Sieghart, W., Brown, D.A., Smart, T.G. and Moss, S.J. (2000) "GABAA receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway", The Journal of Biological Chemistry 275, 38856-38862.
22. Brooks, V.L. and Malvin, R.L. (1979) "An intracerebral, physiological role for angiotensin: effects of central blockade", Federation Proceedings 38, 2272-2275.
23. Bruni, G., Dal Pra, P., Dotti, M.T. and Segre, G. (1980) "Plasma ACTH and cortisol levels in benzodiazepine treated rats", Pharmacological Research Communications 12, 163-175.
24. Caddell, J., Kupiecki, R., Proxmire, D.L., Satoh, P. and Hutchinson, B. (1986) "Plasma catecholamines in acute magnesium deficiency in weanling rats", The Journal of Nutrition 116, 1896-1901.
25. Cade, J.F. (1964) "A significant elevation of plasma levels of magnesium in schizophrenia and depressive states", Medial Journal of Australia 1, 195-196.
26. Campbell, I.G. and Feinberg, I. (1996) "Noncompetitive NMDA channel blockade during waking intensely stimulates NREM delta", Journal of Pharmacology and Experimental Therapeutics 276, 737-742.
27. Carroll, B.J. (1982) "The dexamethasone suppression test for melancholia", British Journal of Psychiatry 140, 292-304.
28. Chao, H.M., Ma, L.Y., McEwen, B.S. and Sakai, R.R. (1998) "Regulation of glucocorticoid receptor and mineralocorticoid receptor messenger ribonucleic acids by selective agonists in the rat hippocampus", Endocrinology 139, 1810-1814.
29. Charlton, J.A. and Armstrong, D.G. (1989) "The effect of an intravenous infusion of aldosterone upon magnesium metabolism in the sheep", Quarterly Journal of Experimental Physiology 74, 329-337.
30. Chollet, D., Franken, P., Raffin, Y., Malafosse, A., Widmer, J. and Tafti, M. (2000) "Blood and brain magnesium in inbred mice and their correlation with sleep quality", American Journal of Physiology-Regulatory Integrative and Comparative Physiology 279, R2173-R2178.
31. Chouinard, G., Beauclair, L., Geiser, R. and Etienne, P. (1990) "A pilot study of magnesium aspartate hydrochloride (Magnesio-card) as a mood stabilizer for rapid cycling bipolar affective disorder patients", Progress in Neuro-Psychopharmacology and Biological Psychiatry 14, 171-180.
32. Chutkow, J.G. (1974) "Metabolism of magnesium in central nervous system. Relationship between concentrations of magnesium in cerebrospinal fluid and brain in magnesium deficiency", Neurology 24, 780-787.
33. Clark, M., Weiss, S.R. and Post, R.M. (1991) "Expression of c-fos mRNA in rat brain after intracerebroventricular administration of corticotropin-releasing hormone", Neuroscience Letters 132, 235-238.
34. Classen, H.G. (1981) "Stress and magnesium", Artery 9, 182-189.
35. Cohan, B.W., Singer, F.R. and Rude, R.K. (1982) "End-organ response to adrenocorticotropin, thyrotropin, gonadotropin-releasing hormone, and glucagon in hypocalcemic magnesium deficient patients", The Journal of Clinical Endocrinology and Metabolism 54, 975-979.
36. Cole, R.L. and Sawchenko, P.E. (2002) "Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus", Journal of Neuroscience 22, 959-969.
37. Connolly, C.N., Kittler, J.T., Thomas, P., Uren, J.M., Brandon, N.J., Smart, T.G. and Moss, S.J. (1999) "Cell surface stability of gamma-aminobutyric acid type A receptors. Dependence on protein kinase C activity and subunit composition", The Journal of Biological Chemistry 274, 36565-36572.
38. Cotton, D.B., Hallak, M., Janusz, C., Irtenkauf, S.M. and Berman, R.F. (1993) "Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures", American Journal of Obstetrics and Gynecology 168, 974-978.
39. Cox, I.M., Campbell, M.J. and Dowson, D. (1991) "Red blood cell magnesium and chronic fatigue syndrome", Lancet 337, 757-760.
40. Czeh, G. and Somjen, G.G. (1989) "Changes in extracellular calcium and magnesium and synaptic transmission in isolated mouse spinal cord", Brain Research 486, 274-285.
41. Dave, J.R. and Eskay, R.L. (1986) "Demonstration of corticotropin-releasing factor binding sites on human and rat erythrocyte membranes and their modulation by chronic ethanol treatment in rats", Biochemical and Biophysical Research Communications 136, 137-144.
42. Davis, M. and Whalen, P.J. (2001) "The amygdala: vigilance and emotion", Molecular Psychiatry 6, 13-34.
43. De Kloet, E.R., Vreugdenhil, E., Oitzl, M.S. and Joels, M. (1998) "Brain corticosteroid receptor balance in health and disease", Endocrine Reviews 19, 269-301.
44. De Souza, E.B. (1995) "Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders", Psychoneuroendocrinology 20, 789-819.
45. De Souza, M.C., Walker, A.F., Robinson, P.A. and Bolland, K. (2000) "A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study", Journal of Womens Health and Gender Based Medicine 9, 131-139.
46. Decollogne, S., Tomas, A., Lecerf, C., Adamowicz, E. and Seman, M. (1997) "NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801", Pharmacology, Biochemistry, and Behavior 58, 261-268.
47. Depoortere, H., Francon, D. and Llopis, J. (1993) "Effects of a magnesium-deficient diet on sleep organization in rats", Neuropsychobiology 27, 237-245.
48. Ditzler, K. (1991) "Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial", Arzneimittel-Forschung 41, 773-780.
49. Donaldson, J., St Pierre, T., Minnich, J. and Barbeau, A. (1971) "Seizures in rats associated with divalent cation inhibition of NA + - K + - ATP'ase", Canadian Journal of Biochemistry 49, 1217-1224.
50. Durlach, J., Bac, P., Bara, M. and Guiet-Bara, A. (2000) "Physiopathology of symptomatic and latent forms of central nervous hyperexcitability due to magnesium deficiency: a current general scheme", Magnesium Research 13, 293-302.
51. Ehlers, C.L., Henriksen, S.J., Wang, M., Rivier, J., Vale, W. and Bloom, F.E. (1983) "Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats", Brain Research 278, 332-336.
52. Ehrhart-Bornstein, M., Bornstein, S.R., Gonzalez-Hernandez, J., Holst, J.J., Waterman, M.R. and Scherbaum, W.A. (1995) "Sympathoadrenal regulation of adrenocortical steroidogenesis", Endocrine Research 21, 13-24.
53. el-Beheiry, H. and Puil, E. (1990) "Effects of hypomagnesia on transmitter actions in neocortical slices", British Journal of Pharmacology 101, 1006-1010.
54. El-Mallakh, R.S. and Wyatt, R.J. (1995) "The Na,K-ATPase hypothesis for bipolar illness", Biological Psychiatry 37, 235-244.
55. El-Mallakh, R.S., Schurr, A., Payne, R.S. and Li, R. (2000) "Ouabain induction of cycling of multiple spike responses in hippocampal slices is delayed by lithium", Journal of Psychiatric Research 34, 115-120.
56. Elam, M., Svensson, T.H. and Thoren, P. (1986) "Locus coeruleus neurons and sympathetic nerves: activation by cutaneous sensory afferents", Brain Research 366, 254-261.
57. Engel, D., Endermann, U., Frahm, C., Heinemann, U. and Draguhn, A. (2000) "Acute effects of gamma-vinyl-GABA on low-magnesium evoked epileptiform activity in vitro", Epilepsy Research 40, 99-107.
58. Engeland, W.C. and Gann, D.S. (1989) "Splanchnic nerve stimulation modulates steroid secretion in hypophysectomized dogs", Neuroendocrinology 50, 124-131.
59. Facchinetti, F., Borella, P., Sances, G., Fioroni, L., Nappi, R.E. and Genazzani, A.R. (1991) "Oral magnesium successfully relieves premenstrual mood changes", Obstetrics and Gynecology 78, 177-181.
60. Farah, Jr., J.M., Rao, T.S., Mick, S.J., Coyne, K.E. and Iyengar, S. (1991) "N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat", Endocrinology 128, 1875-1880.
61. A agonist THIP produces slow wave sleep and reduces spindling activity in nonREM sleep in humans", Psychopharmacology 130, 285-291.
62. Frankiewicz, T. and Parsons, C.G. (1999) "Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices", Neuropharmacology 38, 1253-1259.
63. Franklin, M., Reed, A. and Murck, H. (2002) "Sub-chronic treatment with an extract of Hypericum perforatum (St. John's wort) significantly reduces cortisol and corticosterone in the rat brain", European Neuropsychopharmacology, In press.
64. Friston, K.J., Sharpley, A.L., Solomon, R.A. and Cowen, P.J. (1989) "Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?", Psychopharmacology 98, 139-140.
65. Frizel, D., Coppen, A. and Marks, V. (1969) "Plasma magnesium and calcium in depression", British Journal of Psychiatry 115, 1375-1377.
66. Ganong, W.F. (1993) "Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland", Frontiers in Neuroendocrinology 14, 233-249.
67. Garcy, A.M. and Marotta, S.F. (1978) "Effects of cerebroventricular perfusion with monovalent and divalent cations on plasma cortisol of conscious cats", Neuroendocrinology 26, 32-40.
68. Gard, P.R., Mandy, A. and Sutcliffe, M.A. (1999) "Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression", Biological Psychiatry 45, 1030-1034.
69. George, M.S., Rosenstein, D., Rubinow, D.R., Kling, M.A. and Post, R.M. (1994) "CSF magnesium in affective disorder: lack of correlation with clinical course of treatment", Psychiatry Research 51, 139-146.
70. Gesing, A., Bilang-Bleuel, A., Droste, S.K., Linthorst, A.C., Holsboer, F. and Reul, J.M. (2001) "Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone", Journal of Neuroscience 21, 4822-4829.
71. Giannini, A.J., Nakoneczie, A.M., Melemis, S.M., Ventresco, J. and Condon, M. (2000) "Magnesium oxide augmentation of verapamil maintenance therapy in mania", Psychiatry Research 93, 83-87.
72. Glynn, P., Cooper, D.M. and Schulster, D. (1977) "Modulation of the response of bovine adrenocortical adenylate cyclase to corticotropin", Biochemical Journal 168, 277-282.
73. Gold, P.W. and Chrousos, G.P. (1998) "The endocrinology of melancholic and atypical depression: relation to neurocircuity and somatic consequences", Proceedings of the Association of American Physicians 111, 22-34.
74. Grunze, H. and Walden, J. (1997) "Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs", Magnesium Research 10, 119-126.
75. Guldner, J., Trachsel, L., Kratschmayr, C., Rothe, B., Holsboer, F. and Steiger, A. (1995) "Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men", Psychopharmacology 122, 115-121.
76. Gundersen, V., Danbolt, N.C., Ottersen, O.P, and Storm-Mathisen, J. (1993) "Demonstration of glutamate/aspartate uptake activity in nerve endings by use of antibodies recognizing exogenous D-aspartate", Neuroscience 57, 97-111.
77. Guo, Z., Chen, Y.Z., Xu, R.B. and Fu, H. (1995) "Binding characteristics of glucocorticoid receptor in synaptic plasma membrane from rat brain", Functional Neurology 10, 183-194.
78. Gutierrez, R., Armand, V., Schuchmann, S. and Heinemann, U. (1999) "Epileptiform activity induced by low Mg2+ in cultured rat hippocampal slices", Brain Research 815, 294-303.
79. Halbreich, U., Petty, F., Yonkers, K., Kramer, G.L., Rush, A.J. and Bibi, K.W. (1996) "Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder", American Journal of Psychiatry 153, 718-720.
80. Halili-Manabat, C., Oki, Y., Iino, K., Iwabuchi, M., Morita, H. and Yoshimi, T. (1995) "The role of sodium in mediating adrenocorticotropin secretion by perfused rat anterior pituitary cells", Endocrinology 136, 2937-2942.
81. Hallak, M., Berman, R.F., Irtenkauf, S.M., Evans, M.I. and Cotton, D.B. (1992) "Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats", American Journal of Obstetrics and Gynecology 167, 1605-1610.
82. Hamada, H. and Tsuruo, T. (1988) "Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells", Cancer Research 48, 4926-4932.
83. Hannun, Y.A. and Bell, R.M. (1990) "Rat brain protein kinase C. Kinetic analysis of substrate dependence, allosteric regulation, and autophosphorylation", The Journal of Biological Chemistry 265, 2962-2972.
84. Hasey, G.M., D'Alessandro, E., Cooke, R.G. and Warsh, J.J. (1993) "The interface between thyroid activity, magnesium, and depression: a pilot study", Biological Psychiatry 33, 133-135.
85. Hashizume, N. and Mori, M. (1990) "An analysis of hypermagnesemia and hypomagnesemia", Japanese Journal of Medicine 29, 368-372.
86. Heaton, F.W. and Rayssiguier, Y. (2001) "Magnesium deficiency and membrane properties", In: Altura, Durlach, J. and Seelig, eds, Magnesium in cellular processes and medicine (Karger, Basel), pp. 121-130.
87. Heiden, A., Frey, R., Presslich, O., Blasbichler, T., Smetana, R. and Kasper, S. (1999) "Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy", Psychiatry Research 89, 239-246.
88. 2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans", Pharmacopsychiatry 35, 135-143.
89. Henrotte, J.G., Franck, G., Santarromana, M., Frances, H., Mouton, D. and Motta, R. (1997) "Mice selected for low and high blood magnesium levels: a new model for stress studies", Physiology and Behavior 61, 653-658.
90. Henthorn, T.K., Liu, Y., Mahapatro, M. and Ng, K.Y. (1999) "Active transport of fentanyl by the blood-brain barrier", The Journal of Pharmacology and Experimental Therapeutics 289, 1084-1089.
91. Herman, J.P. and Cullinan, W.E. (1997) "Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis", Trends in Neuroscience 20, 78-84.
92. Herzberg, L. and Herzeberg, B. (1977) "Mood change and magnesium. A possible interaction between magnesium and lithium?", The Journal of Nervous and Mental Disease 165, 423-426.
93. Heuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.H., Nemeroff, C.B. and Holsboer, F. (1998) "Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment", Depression and Anxiety 8, 71-79.
94. Holsboer, F. (1999) "The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety", Journal of Psychiatric Research 33, 181-214.
95. Holsboer, F. (2000) "The corticosteroid receptor hypothesis of depression", Neuropsychopharmacology 23, 477-501.
96. Holsboer, F., von Bardeleben, U. and Steiger, A. (1988) "Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man", Neuroendocrinology 48, 32-38.
97. Honig, A., Arts, B.M., Ponds, R.W. and Riedel, W.J. (1999) "Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice", International Clinical Psychopharmacology 14, 167-171.
98. Horne, A.L., Harrison, N.L., Turner, J.P. and Simmonds, M.A. (1986) "Spontaneous paroxysmal activity induced by zero magnesium and bicuculline: suppression by NMDA antagonists and GABA mimetics", European Journal of Pharmacology 122, 231-238.
99. Horton, R. and Biglieri, E.G. (1962) "Effect of aldosterone on the metabolism of magnesium", Journal of Clinical Endocrinology and Metabolism 22, 1187-1192.
100. Hsu, K.S., Ho, W.C., Huang, C.C. and Tsai, J.J. (2000) "Transient removal of extracellular Mg(2+) elicits persistent suppression of LTP at hippocampal CA1 synapses via PKC activation", Journal of Neurophysiology 84, 1279-1288.
101. Huang, F.L. and Huang, K.P. (1991) "Interaction of protein kinase C isozymes with phosphatidylinositol 4,5-bisphosphate", The Journal of Biological Chemistry 266, 8727-8733.
102. Ichihara, A., Suzuki, H. and Saruta, T. (1993) "Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects", Journal of Laboratory and Clinical Medicine 122, 432-440.
103. Jezova, D., Oliver, C. and Jurcovicova, J. (1991) "Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid", Neuroendocrinology 54, 488-492.
104. Jezova, D., Tokarev, D. and Rusnak, M. (1995) "Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamine release", Neuroendocrinology 62, 326-332.
105. Jezova, D., Ochedalski, T., Kiss, A. and Aguilera, G. (1998) "Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress", Journal of Neuroendocrinology 10, 67-72.
106. Johnson, S. (2001) "The multifaceted and widespread pathology of magnesium deficiency", Medical Hypotheses 56, 163-170.
107. Juhasz, G., Kekesi, K., Emri, Z., Soltesz, I. and Crunelli, V. (1990) "Sleep-promoting action of excitatory amino acid antagonists: a different role for thalamic NMDA and non-NMDA receptors", Neuroscience Letters 114, 333-338.
108. Kantak, K.M. (1988) "Magnesium deficiency alters aggressive behavior and catecholamine function", Behavioral Neuroscience 102, 304-311.
109. Karssen, A.M., Meijer, O.C., van, d.S., Lucassen, P.J., de Lange, E.C., de Boer, A.G. and De Kloet, E.R. (2001) "Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain", Endocrinology 142, 2686-2694.
110. Karst, H., De Kloet, E.R. and Joels, M. (1999) "Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state", European Journal of Neuroscience 11, 889-898.
111. Kemeny, A., Boldizsar, H. and Pethes, G. (1961) "The distribution of cations in plasma and cerebrospinal fluid following infusion of solutions of salts of sodium, potassium, magnesium, and calcium", Journal of Neurochememistry 7, 218-227.
112. Kirov, G.K., Birch, N.J., Steadman, P. and Ramsey, R.G. (1994) "Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms", Neuropsychobiology 30, 73-78.
113. Kling, M.A., Smith, M.A., Glowa, J.R., Pluznik, D., Demas, J., DeBellis, M.D., Gold, P.W. and Schulkin, J. (1993) "Facilitation of cocaine kindling by glucocorticoids in rats", Brain Research 629, 163-166.
114. Kniest, A., Wiesenberg, C., Weber, B., Colla, M., Heuser, I.J. and Deuschle, M. (2001) "The glutamate antagonist riluzole and its effects upon basal and stress-induced activity of the human hypothalamus-pituitary-adrenocortical system in elderly subjects", Neuropsychobiology 43, 91-95.
115. Kohira, I., Akiyama, K., Daigen, A. and Otsuki, S. (1992) "Enduring increase in membrane-associated protein kinase C activity in the hippocampal-kindled rat", Brain Research 593, 82-88.
116. Koob, G.F. (1999) "Corticotropin-releasing factor, norepinephrine, and stress", Biological Psychiatry 46, 1167-118O.
117. Kupfer, D.J., Reynolds, C.F., Weiss, B.L. and Foster, F.G. (1974) "Lithium carbonate and sleep in affective disorders. Further considerations", Archives of General Psychiatry 30, 79-84.
118. Lancel, M. (1997) "The GABA(A) agonist THIP increases non-REM sleep and enhances non-REM sleep-specific delta activity in the rat during the dark period", Sleep 20, 1099-1104.
119. A agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat", Neuroreport 7, 2241-2245.
120. Landfield, P.W. and Morgan, G.A. (1984) "Chronically elevating plasma Mg2 + improves hippocampal frequency potentiation and reversal learning in aged and young rats", Brain Research 322, 167-171.
121. Landfield, P.W., Pitler, T.A. and Applegate, M.D. (1986) "The effects of high Mg2 + -to-Ca2 + ratios on frequency potentiation in hippocampal slices of young and aged rats", Journal of Neurophysiology 56, 797-811.
122. Leppert, J., Myrdal, U., Hedner, T., Edvinsson, L., Tracz, Z. and Ringqvist, I. (1994) "Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon", Angiology 45, 637-645.
123. Li, R., El-Mallakh, R.S., Harrison, L., Changaris, D.G. and Levy, R.S. (1997) "Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression", Molecular Chemistry and Neuropathology 31, 65-72.
124. Linder, J., Brismar, K., Beck-Friis, J., Saaf, J. and Wetterberg, L. (1989) "Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms", Acta Psychiatrica Scandinavica 80, 527-537.
125. Linkowski, P., Mendlewicz, J., Kerkhofs, M., Leclercq, R., Golstein, J., Brasseur, M., Copinschi, G. and Van Cauter, E. (1987) "24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment", Journal of Clinical Endocrinology and Metabolism 65, 141-152.
126. Manji, H.K. and Chen, G. (2002) "PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers", Molecular Psychiatry 7(Suppl. 1), S46-S56.
127. Manji, H.K. and Lenox, R.H. (2000) "The nature of bipolar disorder", Journal of Clinical Psychiatry 61(Suppl. 13), 42-57.
128. Martin, D., McNamara, J.O. and Nadler, J.V. (1992) "Kindling enhances sensitivity of CA3 hippocampal pyramidal cells to NMDA", Journal of Neuroscience 12, 1928-1935.
129. Mathias, S., Wetter, T.C., Steiger, A. and Lancel, M. (2001) "The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects", Neurobiology of Aging 22(2), 247-253.
130. McEwen, B.S., Brinton, R.E. and Sapolsky, R.M. (1988) "Glucocorticoid receptors and behavior: implications for the stress response", Advances in Experimental Medicine and Biology 245, 35-45.
131. Miguez, I. and Aldegunde, M.A. (1990) "Effect of gamma-aminobutyric acid on corticosterone secretion: involvement of the noradrenergic system", Life Sciences 46, 875-880.
132. Minabe, Y., Emori, K. and Kurachi, M. (1988) "Effects of chronic lithium treatment on limbic seizure generation in the cat", Psychopharmacology (Berlin) 96, 391-394.
133. Mork, A. (1993) "Actions of lithium on the cyclic AMP signalling system in various regions of the brain-possible relations to its psychotropic actions. A study on the adenylate cyclase in rat cerebral cortex, corpus striatum and hippocampus", Pharmacology and Toxicology 73(Suppl. 3), 1-47.
134. Mork, A. and Geisler, A. (1987) "Mode of action of lithium on the catalytic unit of adenylate cyclase from rat brain", Pharmacology and Toxicology 60, 241-248.
135. Morris, M.E. (1992) "Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms", Magnesium Research 5, 303-313.
136. Müller-Oerlinghausen, B. and Berghofer, A. (1999) "Antidepressants and suicidal risk", Journal of Clinical Psychiatry 60(Suppl. 2), 94-99.
137. Murck, H. (2002) "Atypical depression and related disorders-neurobiological basis and their treatment with St. John's wort", Wiener Medizinische Wochenschrift 152(15-16), 398-403.
138. 2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men-possible therapeutical implications", Psychopharmacology 137, 247-252.
139. Murck, H., Antonijevic, I.A., Frieboes, R.M. and Steiger, A. (1999) "Altered peripheral MR-related changes after sleep deprivation in depression", Biological Psychiatry 45, 65S.
140. Murck, H., Held, K., Künzel, H. and Steiger, A. (2002a) "Sleep-endocrine changes in depression and the effect of sleep deprivation-focus on the renin-angiotensin-aldosterone system", European Archives of Psychiatry and Clinical Neuroscience 252(Suppl. 1), 27.
141. Murck, H., Sinner, C. and Singewald, N. (2002b) "Magnesium-depletion von Mäusen als Modell für Angst und Depression-Beeinflussbarkeit durch Johanniskraut-Extrakt und Desipramin", Nervenheilkunde, in press.
142. Nakai, T., Ueda, M. and Takeda, R. (1978) "Effects of calcium and magnesium ions on the interaction of corticosterone with rat brain cytosol receptor(s)", Endocrine Research Communications 5, 81-90.
143. Naylor, G.J., Fleming, L.W., Stewart, W.K., McNamee, H.B. and Le Poidevin, D. (1972) "Plasma magnesium and calcium levels in depressive psychosis", British Journal of Psychiatry 120, 683-684.
144. Nemeroff, C.B., Widerlov, E., Bissette, G., Walleus, H., Karlsson, I., Eklund, K., Kilts, C.D., Loosen, P.T. and Vale, W. (1984) "Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients", Science 226, 1342-1344.
145. Nemeroff, C.B., Musselman, D.L. and Evans, D.L. (1998) "Depression and cardiac disease", Depression and Anxiety 8(Suppl. 1), 71-79.
146. Neri, G., Andreis, P.G., Prayer-Galetti, T., Rossi, G.P., Malendowicz, L.K. and Nussdorfer, G.G. (1996) "Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines", The Journal of Clinical Endocrinology and Metabolism 81, 169-173.
147. Newman, M.E. and Belmaker, R.H. (1987) "Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat", Neuropharmacology 26, 211-217.
148. Nickel, T., Sonntag, A., Schill, J., Zobel, A.W., Ackl, N., Brunnauer, A., Murck, H., Ising, M., Yassouridis, A., Steiger, A., Zihl, J. and Holsboer, F. (2001) "Clinical and neurobiological effects of tianeptine and paroxetine in major depression", Journal of Clinical Psychopharmacology, In press.
149. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. and Prochiantz, A. (1984) "Magnesium gates glutamate-activated channels in mouse central neurones", Nature 307, 462-465.
150. Nowak, G., Legutko, B., Skolnick, P. and Popik, P. (1998) "Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors", European Journal of Pharmacology 342, 367-370.
151. Oh, S., Jang, C.G., Ma, T. and Ho, I.K. (1999) "Activation of protein kinase C by phorbol dibutyrate modulates GABAA receptor binding in rat brain slices", Brain Research 850, 158-165.
152. Ono, M., Akiyama, K., Tsutsui, K. and Kuroda, S. (1994) "Differential changes in the activities of multiple protein kinase C subspecies in the hippocampal-kindled rat", Brain Research 660, 27-33.
153. Oppelt, W.W., MacInyre, I. and Rall, D.P. (1963) "Magnesium exchange between blood and cerebrospinal fluid", American Journal of Physiology 205, 959-962.
154. Pavlinac, D., Langer, R., Lenhard, L. and Deftos, L. (1979) "Magnesium in affective disorders", Biological Psychiatry 14, 657-661.
155. Perrin, M.H., Haas, Y., Rivier, J.E. and Vale, W.W. (1986) "Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides", Endocrinology 118, 1171-1179.
156. Petty, F. (1995) "GABA and mood disorders: a brief review and hypothesis", Journal of Affective Disorders 34, 275-281.
157. Petty, F., McChesney, C. and Kramer, G. (1985) "Intracortical glutamate injection produces helpless-like behavior in the rat", Pharmacology, Biochemistry and Behavior 22, 531-533.
158. Pittaluga, A., Bonfanti, A. and Raiteri, M. (2000) "Somatostatin potentiates NMDA receptor function via activation of InsP(3) receptors and PKC leading to removal of the Mg(2+) block without depolarization", British Journal of Pharmacology 130, 557-566.
159. Pivac, N. and Pericic, D. (1993) "Inhibitory effect of diazepam on the activity of the hypothalamic-pituitary-adrenal axis in female rats", Journal of Neural Transmission-General Section 92, 173-186.
160. Poenaru, S., Rouhani, S., Durlach, J., Aymard, N., Belkahla, F., Rayssiguier, Y. and Iovino, M. (1984) "Vigilance states and cerebral monoamine metabolism in experimental magnesium deficiency", Magnesium 3, 145-151.
161. Poenaru, S., Manicom, R., Rouhani, S., Aymard, P., Bajenaru, O., Rayssiguier, Y., Emmanouillidis, E., Gueux, E., Nkanga, N., Durlach, J. and Dall'ava, J. (1997) "Stability of brain content of magnesium in experimental hypomagnesemia", Brain Research 769, 329-332.
162. Pohl, M., Straub, H. and Speckmann, E.J. (1992) "Low magnesium-induced epileptiform discharges in guinea pig hippocampal slices: depression by the organic calcium antagonist verapamil", Brain Research 577, 29-35.
163. Post, R.M. (1990) "Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine", Pharmacopsychiatry 23, 3-17.
164. Post, R.M., Weiss, S.R. and Pert, A. (1984) "Differential effects of carbamazepine and lithium on sensitization and kindling", Progress in Neuropsychopharmacology and Biological Psychiatry 8, 425-434.
165. Pratt, J.H. and McAteer, J.A. (1989) "Beta-adrenergic enhancement of angiotensin II-stimulated aldosterone secretion", Life Sciences 44, 2089-2095.
166. Puca, F.M., Bricolo, A. and Turella, G. (1973) "Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism", Electroencephalography and Clinical Neurophysiology 35, 327-330.
167. Rasmussen, H.H., Mortensen, P.B. and Jensen, I.W. (1989) "Depression and magnesium deficiency", International Journal of Psychiatry in Medicine 19, 57-63.
168. Reiner, P.B. (1986) "Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving cats", Brain Research 378, 86-96.
169. Reul, J.M., Stec, I., Soder, M. and Holsboer, F. (1993) "Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system", Endocrinology 133, 312-320.
170. Reul, J.M., Gesing, A., Droste, S., Stec, I.S., Weber, A., Bachmann, C., Bilang-Bleuel, A., Holsboer, F. and Linthorst, A.C. (2000) "The brain mineralocorticoid receptor: greedy for ligand, mysterious in function", European Journal of Pharmacology 405, 235-249.
171. Robinson, J.D. (1972) "Divalent cations as allosteric modifiers of the (Na+ + K+)-dependent ATPase", Biochimica et Biophysica Acta 266, 97-102.
172. Robinson, M.B., Sinor, J.D., Dowd, L.A. and Kerwin, Jr., J.F. (1993) "Subtypes of sodium-dependent high-affinity L-[3H]glutamate transport activity: pharmacologic specificity and regulation by sodium and potassium", Journal of Neurochemistry 60, 167-179.
173. Saunders, N. and Hammersley, B. (1995) "Magnesium for eclampsia", Lancet 34, 788-789.
174. Schain, R.J. (1964) "Cerebrospinal fluid serum cation levels", Archives of Neurology 11, 330-333.
175. Schmidt, J. (1986) "Lithium suppresses seizure susceptibility in pentylenetetrazol-kindled rats", Biomedica Biochimica Acta 45, 1167-1172.
176. Schneiderman, J.H., Arnold, D. and Advani, A. (1990) "Different changes in spontaneous field potential oscillations precede epileptiform bursting in hippocampal slices perfused with penicillin or reduced magnesium", Brain Research 533, 275-285.
177. Schulkin, J., Gold, P.W. and McEwen, B.S. (1998) "Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load", Psychoneuroendocrinology 23, 219-243.
178. Schwartz, R.D., Wagner, J.P., Yu, X. and Martin, D. (1994) "Bidirectional modulation of GABA-gated chloride channels by divalent cations: inhibition by Ca2+ and enhancement by Mg2+", Journal of Neurochemistry 62, 916-922.
179. Shiekhattar, R. and Aston-Jones, G. (1992) "NMDA-receptor-mediated sensory responses of brain noradrenergic neurons are suppressed by in vivo concentrations of extracellular magnesium", Synapse 10, 103-109.
180. Shricker, K., Holmer, S., Kramer, B.K., Riegger, G.A. and Kurtz, A. (1997) "The role of angiotensin II in the feedback control of renin gene expression", Pflügers Archiv-European Journal of Physiology 434, 166-172.
181. Skou, J.C. (1974) "Effect of ATP on the intermediary steps of the reaction of the (Na+ plus K+)-dependent enzyme system. II. Effect of a variation in the ATP-Mg2+ ratio", Biochimica et Biophysica Acta 339, 246-257.
182. Smith, B.N. and Dudek, F.E. (1994) "Age-related epileptogenic effects of corticotropin-releasing hormone in the isolated CA1 region of rat hippocampal slices", Journal of Neurophysiology 72, 2328-2333.
183. Standley, C.A., Irtenkauf, S.M., Stewart, L., Mason, B. and Cotton, D.B. (1994) "Magnesium sulfate versus phenytoin for seizure prevention in amygdala-kindled rats", American Journal of Obstetrics and Gynecology 171, 948-951.
184. Standley, C.A., Irtenkauf, S.M. and Cotton, D.B. (1995) "Anticonvulsant effects of magnesium sulfate in hippocampal-kindled rats", Journal of Biomedical Science 2, 57-62.
185. Steiger, A., von Bardeleben, U., Wiedemann, K. and Holsboer, F. (1991) "Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission", Journal of Psychiatric Research 25, 169-177.
186. Stella, A., Macchi, A., Genovesi, S., Centonza, L. and Zanchetti, A. (1989) "Angiotensin converting enzyme inhibition and renin release from the kidney", Journal of Hypertension-Supplement 7, S21-S25.
187. Stevens, D.R., McCarley, R.W. and Greene, R.W. (1992) "Excitatory amino acid-mediated responses and synaptic potentials in medial pontine reticular formation neurons of the rat in vitro", Journal of Neuroscience 12, 4188-4194.
188. Stewart, C.A. and Reid, I.C. (2002) "Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission", Moecular Psychiatry 7(Suppl. 1), S15-S22.
189. Stoll, A.L., Locke, C.A., Vuckovic, A. and Mayer, P.V. (1996) "Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: a case series", Journal of Clinical Psychiatry 57, 356-359.
190. Sumitomo, T., Suda, T., Nakano, Y., Tozawa, F., Yamada, M. and Demura, H. (1991) "Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus", Endocrinology 128, 2248-2252.
191. Swaab, D.F., Fliers, E., Hoogendijk, W.J., Veltman, D.J. and Zhou, J.N. (2000) "Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression", Progress in Brain Research 126, 369-396.
192. Szafarczyk, A., Caracchini, M., Rondouin, G., Ixart, G., Malaval, F. and Assenmacher, I. (1986) "Plasma ACTH and corticosterone responses to limbic kindling in the rat", Experimental Neurology 92, 583-590.
193. Thase, M.E. (1998) "Depression, sleep, and antidepressants", Journal of Clinical Psychiatry 59(Suppl. 4), 55-65.
194. Tramer, M.R., Schneider, J., Marti, R.A. and Rifat, K. (1996) "Role of magnesium sulfate in postoperative analgesia", Anesthesiology 84, 340-347.
195. Transbol, I., Christiansen, C., Baastrup, P.C., Nielsen, M.D. and Giese, J. (1978) "Endocrine effects of lithium. III. Hypermagnesaemia and activation of the renin-aldosterone system", Acta Endocrinologica 88, 619-624.
196. Trullas, R. and Skolnick, P. (1990) "Functional antagonists at the NMDA receptor complex exhibit antidepressant actions", European Journal of Pharmacology 185, 1-10.
197. Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T. and Hori, R. (1992) "Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone", The Journal of Biological Chemistry 267, 24248-24252.
198. Walden, J., Grunze, H., Bingmann, D., Liu, Z. and Dusing, R. (1992) "Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies", European Neuropsychopharmacology 2, 455-462.
199. Walker, A.F., De Souza, M.C., Vickers, M.F., Abeyasekera, S., Collins, M.L. and Trinca, L.A. (1998) "Magnesium supplementation alleviates premenstrual symptoms of fluid retention", Journal of Womens Health 7, 1157-1165.
200. Whyte, K.F., Addis, G.J., Whitesmith, R. and Reid, J.L. (1987) "Adrenergic control of plasma magnesium in man", Clinical Science 72, 135-138.
201. Widmer, J., Bovier, P., Karege, F., Raffin, Y., Hilleret, H., Gaillard, J.M. and Tissot, R. (1992) "Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months", Neuropsychobiology 26, 173-179.
202. Widmer, J., Henrotte, J.G., Raffin, Y., Bovier, P., Hilleret, H. and Gaillard, J.M. (1995) "Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients", Journal of Affective Disorders 34, 201-209.
203. Wojtowicz, J.M., Marshall, K.C. and Hendelman, W.J. (1977) "Depression by magnesium ion of neuronal excitability in tissue cultures of central nervous system", Canadian Journal of Physiology and Pharmacology 55, 367-372.
204. Wolf, M., Cuatrecasas, P. and Sahyoun, N. (1985) "Interaction of protein kinase C with membranes is regulated by Ca2 +, phorbol esters, and ATP", The Journal of Biological Chemistry 260, 15718-15722.
205. Wolkowitz, O.M. and Reus, V.I. (1999) "Treatment of depression with antiglucocorticoid drugs", Psychosomatic Medicine 61, 698-711.
206. Wong, M.L., Kling, M.A., Munson, P.J., Listwak, S., Licinio, J., Prolo, P., Karp, B., McCutcheon, I.E., Geracioti, T.D.J., DeBellis, M.D., Rice, K.C., Goldstein, D.S., Veldhuis, J.D., Chrousos, G.P., Oldfield, E.H., McCann, S.M. and Gold, P.W. (2000) "Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone", Proceedings of the National Academy of Science of the United States of America 97, 325-330.
207. Xiong, Z.G., Raouf, R., Lu, W.Y., Wang, L.Y., Orser, B.A., Dudek, E.M., Browning, M.D. and MacDonald, J.F. (1998) "Regulation of N-methyl-D-aspartate receptor function by constitutively active protein kinase C", Molecular Pharmacology 54, 1055-1063.
208. Young, L.T., Robb, J.C., Levitt, A.J., Cooke, R.G. and Joffe, R.T. (1996) "Serum Mg2+ and Ca2+/Mg2+ ratio in major depressive disorder", Neuropsychobiology 34, 26-28.
209. Zhu, Z., Tepel, M., Spieker, C. and Zidek, W. (1995) "Effect of extracellular Mg2+ concentration on agonist-induced cytosolic free Ca2+ transients", Biochimica et Biophysica Acta 1265, 89-92.
210. Ziegler, D.R. and Herman, J.P. (2000) "Local integration of glutamate signaling in the hypothalamic paraventricular region: regulation of glucocorticoid stress responses", Endocrinology 141, 4801-4804.
211. Zobel, A.W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F. and Ising, M. (2001) "Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study", Journal of Psychiatric Research 35, 83-94.
212. Zofkova, I., Lamberg-Allardt, C., Kancheva, R.L. and Starka, L. (1993) "Effect of hypermagnesemia on the adenohypophyseal-gonadal function, parathyroid hormone secretion and some other hormonal indicators", Hormone and Metabolic Research 25, 29-33.
213. Zubenko, G.S. and Nixon, R.A. (1984) "Mood-elevating effect of captopril in depressed patients", American Journal of Psychiatry 141, 110-111.